Background: Peripheral nerve hyperexcitability (PNH) is characterized by muscle overactivity due
ized by doublet, triplet, or multiplet motor unit or partial motor unit potentials, which predict more severe and more diverse motor symptoms. However, the electrophysiologic phenotype can change with time. 3 PNH is commonly caused by a loss of function of voltage-gated potassium channels (VGKC) resulting in a decreased potassium outward current. 9 VGKCs regulate neuronal firing by contributing to the repolarizing phase of the action potential and by setting the membrane potential in the subthreshold range. 10 In autoimmune mediated PNH, loss of VGKCs is caused in fewer than 50% by antibodies against these channels. Furthermore, ion channel mutations may cause PNH in conjunction with a complex phenotype such as episodic ataxia with myokymia (EA-1) for which mutations in the gene KCNA1, encoding the human homolog of the Shaker potassium channel K V 1.1, have been identified. [11] [12] [13] [14] For PNH combined with neonatal epilepsy, a single mutation in the KCNQ2 gene encoding the potassium channel K V 7.2 has been reported. 15 Neuronal K V 7 channels generate the M-current, a non-inactivating potassium current which is particularly important to regulate excitability in many neurons by influencing the subthreshold membrane potential. 16 Many mutations have been described in K V 7.2 channels, and a few ones in K V 7.3, to cause benign familial neonatal convulsions (BFNC), an autosomal dominantly inherited epilepsy syndrome characterized by seizures in the first days and weeks of life. 17 Functional analysis of these BFNC-causing mutations revealed a more or less complete loss of function without a prominent dominant negative effect on wild type (WT) channels. Therefore, a haploinsufficiency is commonly believed to induce seizures in BFNC. [18] [19] [20] [21] [22] [23] [24] Although these channels are not only detected in the CNS but also highly expressed in peripheral nerves, 15, 25 only one of the many mutations is associated with clinically manifest PNH in addition to BFNC. This mutation predicts the loss of a positive charge within the K V 7.2 channel's voltage sensor (R207W) and has a unique functional consequence: it leads to a large positive shift of voltagedependent activation resulting in a pronounced dominant negative effect on the WT channel for the first 200 msec after onset of the depolarization. 15 Here we describe a second mutation at the same position in the voltage sensor region of K V 7.2, being associated with sporadic PNH without evidence for neonatal seizures in a single patient of Egyptian origin, and without evidence for PNH or BFNC in his family. We present a video of typical myokymia in the distal upper limbs, typical electromyographic recordings, and a detailed functional analysis of both K V 7.2 mutations associated with PNH. Our results emphasize the important role of K V 7.2 channels at subthreshold membrane potentials and suggest a distinct sensitivity of peripheral and central neurons to a reduction of the M-current in different stages of development. Furthermore, we provide evidence for a potentially therapeutic effect of the new anticonvulsant compound retigabine, a specific K V 7 channel activator, on PNH.
METHODS Subjects. All patients and their unaffected relatives (or their legal representatives) gave written informed consent to participate in the study. All studies conformed to the standards set by the Declaration of Helsinki, and all procedures were approved by the Ethical Committee of the University of Ulm, Germany. The index patient was personally interviewed and examined by experienced neurologists (F.L.H., W.P.).
Mutation analysis. Genomic DNA was extracted by standard methods. The coding regions and exon-intron boundaries of KCNQ2 22 and of the single exon encoding KCNA1
were amplified by PCR using previously published PCR primers. Gel purified products were automatically sequenced and patient sequences were compared to published sequences for KCNQ2 (GenBank, NM_172107) and KCNA1 (GenBank, NM_000217).
Mutagenesis and RNA preparation. Site-directed mutagenesis using PCR techniques was performed to introduce both mutations in the KCNQ cDNA cloned in the pTLN vector (primers are available upon request). Both mutations were verified by automated DNA sequencing. Plasmids were linearized by digestion with the restriction enzyme MluI. Linearized plasmids were transcribed in vitro using the SP6 mMessage mMachine kit (Ambion Inc., Austin, TX) resulting in capped cRNA. Purity was checked by gel electrophoresis. Concentration was verified by spectrophotometry.
Oocyte preparation and injection. All procedures met the NIH guidelines for the care and use of laboratory animals and were approved by the Regierungspraesidium Electrophysiology and data evaluation. Potassium currents were recorded using standard two-microelectrode voltage clamping, a Turbo TEC01C amplifier (npi electronic GmbH, Tamm, Germany), and pClamp data acquisition (Axon instruments, Foster City, CA), as described previously. 26 Frog Ringer (see above) was used as the bathing solution for all recordings. Recording electrodes were filled with 3 M KCl and had a resistance of 0.3 to 1 M⍀. Currents were low-pass filtered at 0.3 kHz and sampled at 1 kHz. Oocytes were clamped to a holding potential of Ϫ80 mV followed by depolarizing pulses in 10 mV steps up to ϩ60 mV. Due to the slow time course of activation in the mutants, pulses with a duration of up to 5 s were used. Tail currents were recorded at Ϫ30 mV and their amplitudes analyzed to obtain conductance-voltage plots. To evaluate the current reduction after shorter depolarizations, current amplitudes were analyzed after 200 msec and normalized to those at the end of a 5-s (mutant) or 2-s (WT) depolarization to ϩ60 mV (maximal activation).
Experiments with retigabine (RGB) were performed as described previously. 27 Oocytes were clamped to a holding potential of Ϫ100 mV and depolarized in 20-mV steps up to ϩ20 mV. Solutions with different concentrations of retigabine (0 M, 1 M, 10 M, 100 M) were used to obtain dose-response curves. RGB caused a hyperpolarizing shift of the steady-state activation curve. V 0.5 Ϫ V 0.5 (ϩRGB) was plotted against the logarithm of the RGB concentration. A Hill function was fit to the data points according to the following equation:
where V 0.5 Ϫ V 0.5 (ϩRGB) represents the difference in V 0.5 of the activation curve (see below) in presence and absence of RGB, A 1 is the minimal and A 2 the maximal hyperpolarizing shift, x the concentration of RGB, x 0 the EC 50 (concentration of RGB resulting in the half-maximal hyperpolarizing shift of the activation curve), and n H the slope factor (Hill coefficient) of the curve. Data were analyzed using pClamp, Microsoft Excel (Microsoft, Redmond, WA), and Origin (Microcal Software, Northampton, MA) software. A Boltzmann equation was fit to conductance-voltage relationships (activation curves):
with I/I max being the normalized tail current amplitude, V 0.5 the voltage of half-maximal activation, and k a slope factor. Time constants of activation and deactivation were obtained by fitting a first order exponential function to the rising part of the current traces or to the tail current decay.
For statistical evaluation a two-tailed, unpaired Student t-test test was applied (p Ͻ 0.05 was considered to be significant). All data are shown as means Ϯ SEM.
RESULTS Clinical data. The index patient of the Egyptian family is the only individual affected by PNH ( figure 1A ). He has no history of neonatal seizures. He was 25 years old at the time that studies were performed. He presented with a permanent muscle overactivity which was best visible in the distal upper extremities as small amplitude movements of his fingers. A video of these spontaneous movements in the patient's right hand can be seen on the Neurology ® Web site. These involuntary movements are not disabling for him. He denied problems with writing, typing, or other motor skills using the hands. The patient could not tell if the involuntary movements also occur during sleep. He was not willing to come overnight to the hospital for monitoring or other further investigations. In addition to the permanent overactivity, the patient reported exercise-induced cramps primarily of both hands since the age of 6 years. Extensive physical exertion and anxiety can lead to periods with severe generalized muscle stiffness lasting up to 30 minutes, which happened four times in his life. These events were threatening for him and he therefore avoids heavy exercising. Both the index patient and his mother denied any symptoms which could be attributed to neonatal or other epileptic seizures during his life. His neurologic examination was otherwise unremarkable, including absence of muscle hypertrophy and sensory symptoms. Treatment with carbamazepine was unsuccessful and was discontinued due to a rash, but lamotrigine in a dosage of 200 mg per day was of some benefit.
Electromyography of thenar muscles revealed spontaneous discharges mainly in form of irregular multiplets (figure 1B), consistent with myokymic discharges as a typical phenotype of PNH. 3 Motor and sensory nerve conduction studies revealed normal results.
None of the other family members, who all live in Egypt, was reported to have experienced symptoms of PNH or BFNC.
Molecular genetic analysis. Blood samples were obtained from the index patient and from his mother during a short visit in Germany. All other family members refused a genetic analysis. While sequencing of the KCNA1 gene did not reveal any changes, the KCNQ2 gene revealed a heterozygous point mutation predicting the loss of a charged residue in the voltage sensor (segment S4) of the K V 7.2 channel (substitution of glutamine for the third of six highly conserved arginines, R207Q (figure 1, C and D). His mother did not carry the mutation. Further mutations in KCNQ2 were not detected by sequencing all exons including adjacent splice sites. The mutation was excluded in 98 healthy controls.
Electrophysiology. To characterize the functional consequences of the two only KCNQ2 mutations identified up to now to be associated with PNH, the one described previously by Dedek et al., 15 R207W, and the new one found in this study, R207Q, both were heterologously expressed as homomers and in various combinations with K V 7.2 and K V 7.3 in Xenopus laevis oocytes. Potassium currents were recorded using standard two-microelectrode voltage clamping. Oocytes were depolarized from a holding potential of Ϫ80 mV in 10 mV steps up to ϩ60 mV followed by a pulse to Ϫ30 mV to record tail currents and construct conductance-voltage curves. Raw current traces are shown in figure 2A and figure 3A revealing a prominent slowing of the activation time course for both mutations compared to the WT. Maximal current amplitudes of the homomeric and heteromeric mutant channels were not decreased in comparison to WT channels (examples are shown in figure 2A and figure 3A) . Conductance-voltage curves were strongly shifted, by ϩ25 mV for R207Q and ϩ53 mV for R207W channels, as compared to K V 7.2 WT channels (figure 2B). Co-expression studies of mutant with WT K V 7.2 channels in a 1:1 ratio demonstrated a reduction of the normalized steady-state conductance at subthreshold potentials between Ϫ50 and Ϫ30 mV which was slightly stronger than 50%, as would be expected for a haploinsufficiency ( figure 2B dashed line) . Thus even in the steady state, we obtained evidence for a mild dominant negative effect of both mutants upon co-expression with WT K V 7.2 channels. However, spontaneous discharges of peripheral motor neurons will hardly involve 5 s lasting depolarizations (compare figure 1B) and the strong slowing of the activation time course predicted a much larger reduction of current amplitudes after short-lasting depolarizations. To evaluate this effect, amplitudes of currents conducted by mutant channels as measured 200 msec after onset of the depolarization were normalized to the maximum amplitude reached after 5 s at ϩ60 mV and compared to the respective amplitudes of the WT normalized to the maximum amplitude reached after 2 s at ϩ60 mV. Using this method, we observed a very strong dominant negative effect of both mutations on WT K V 7.2 chan- 2: V 0.5 ϭ Ϫ17.6 Ϯ 3.0 mV, k ϭ Ϫ14.7 Ϯ 1.0 mV, exhibiting a strong depolarizing shift of the activation curves of R207Q (n ϭ 21; p Ͻ 1 E-15), R207Q/K V 7.2 (n ϭ 7; p Ͻ 1 E-9), R207W (n ϭ 12; p Ͻ 1 E-13), and R207W/K V 7.2 (n ϭ 5; p Ͻ 1 E-7) in comparison to K V 7.2 (n ϭ 14). Comparison to the assumed 50% current reduction in case of a haploinsufficiency of K V 7.2 (dashed line) predicted a dominant negative effect for both R207Q and R207W when co-expressed with K V 7.2 at subthreshold potentials (R207Q/K V 7.2: Ϫ50 mV: p Ͻ 0.001; Ϫ40 mV: p Ͻ 1 E-5; R207W/K V 7.2: Ϫ50: p Ͻ 0.05; Ϫ40: p Ͻ 0.01). Data are shown as means Ϯ SEM. (C) To evaluate the current reduction after short-term depolarizations, amplitudes of currents mediated by mutant channels were determined after 200 msec and normalized to the current amplitude at ϩ60 mV after a 5 s depolarization and compared to the respective amplitudes for the WT normalized to the maximum amplitude reached after 2 s at ϩ 60 mV. Relative current amplitudes of the co-expressions R207Q/K V 7.2 and R207W/K V 7.2 were reduced in comparison to K V 7.2 for a broad range of potentials and were as follows at e.g., Ϫ40 mV: K V 7.2: 0.039 Ϯ 0.007; R207Q/K V 7.2: 0.000 Ϯ 0.002 (p Ͻ 0.01); R207W/K V 7.2: 0.010 Ϯ 0.006 (p Ͻ 0.05). Comparison to the assumed 50% reduction of current in case of a haploinsufficiency of the K V 7.2 WT (n ϭ 9) (dashed line) predicted a strong dominant negative effect for both R207Q and R207W when co-expressed with K V 7.2 (n ϭ 6, 4) with a Ͼ 70% reduction of the relative current amplitude for potentials between Ϫ40 and ϩ10 mV. Parameters are given as means Ϯ SEM. (D) Time constants of activation ( act ) for K V 7.2 (n ϭ 10), R207Q (n ϭ 10), R207W (n ϭ 10) and the co-expressions R207Q/K V 7.2 (n ϭ 7), R207W/K V 7.2 (n ϭ 5) were obtained by fitting a first order exponential function to the rising part of each current trace. Means for act Ϯ SEM were plotted against voltage, revealing a pronounced slowing of activation kinetics for both mutants. Activation time constants were different for all plotted potentials (p Ͻ 1 E-7). (E) Time constants of deactivation ( deact ) of K v 7.2 (n ϭ 8), R207Q (n ϭ 8), R207W (n ϭ 5), and the co-expressions R207Q/K v 7.2 (n ϭ 8), R207W/K v 7.2 (n ϭ 4 -5) were evaluated by fitting a first order exponential function to the tail current decay at different potentials after a 5-second lasting depolarizing pulse to ϩ50. Data for deact were plotted against voltage and are shown as means Ϯ SEM.
nels for a physiologically relevant time range with a Ͼ70% reduction of current amplitudes at potentials between Ϫ40 and ϩ10 mV when compared to K V 7.2 channels alone ( figure 2C ). The marked slowing of the activation time course for R207W Ͼ R207Q and the co-expressions with K V 7.2 WT channels are shown in figure 2D . Deactivation kinetics showed a loss of voltage dependence for homomeric mutant channels but were only slightly slowed for heteromeric R207Q/ K V 7.2 and R207W/K V 7.2 channels (figure 2E). Heteromeric K V 7.2/K V 7.3 channels have much larger amplitudes compared to the individual channels alone and could represent the most abundant morphologic correlate of the M-current in the mammalian brain. 16, 28, 29 Taking into account a potential colocalization of K V 7.2 and K V 7.3 subunits also in peripheral motor neurons, we evaluated the functional consequences of the R207Q and R207W mutants when co-expressed with K V 7.3 channels. We compared currents in oocytes injected with the same total amount of cRNA 1) for a 1:1 co-expression of K V 7.2 and K V 7.3 WT channels, 2) for R207Q or R207W with K V 7.3 in a 1:1 ratio, and 3) for each of the mutants with K V 7.2 and K V 7.3 in a 1:1:2 ratio (to mimic the potential situation in an affected individual carrying one mutant KCNQ2, one WT KCNQ2, and two WT KCNQ3 alleles). The effects observed under these conditions were similar to those with a K V 7.2 co-expression but less pronounced for R207Q. Conductance-voltage curves in the steady-state for co-expressions of each of the mutants with K V 7.3 showed clear depolarizing shifts for R207W and R207Q compared to K V 7.2/K V 7.3 WT channels; the effect was much more pronounced for R207W ( figure  3B ). This shift was still statistically significant for the co-expression of R207W/K V 7.2/K V 7.3 channels, but there was no significant difference for R207Q/K V 7.2/K V 7.3 compared to K V 7.2/K V 7.3 alone (figure 3B). A similar scenario was observed for the current-voltage relationship when current amplitudes were analyzed 200 msec after onset of the depolarization ( figure 3C ). Except for R207Q/ K V 7.2/K V 7.3, activation time constants ( act ) were increased compared to K V 7.2/K V 7.3 channels (figure 3D) . Deactivation time constants were slowed for all co-expressions ( figure 3E) .
Recordings before and after application of different concentrations of retigabine, a new anticonvulsant drug activating neuronal K V 7 channels, revealed a concentration-dependent hyperpolarizing shift of the activation curves (figure 4B): 25 mV for K V 7.2 WT and 27 mV for R207Q after washing in of 100 M retigabine ( figure 4A ). This effect resulted in an increase of the relative current amplitude over a broad range of membrane potentials (figure 4A inset). The retigabine sensitivity was not altered for the mutation (figure 4B), indicating that the decrease in channel activity could be largely rescued by this drug.
DISCUSSION KCNQ2 and KCNQ3 mutations usually cause BFNC without PNH, although K V 7.2 and K V 7.3 channels are also expressed within the peripheral nervous system. 15, 25 All functional studies of these mutations revealed a haploinsufficiency of the KCNQ2 or the KCNQ3 gene as a common pathogenetic mechanism for BFNC. [22] [23] [24] A 50% reduction of potassium currents carried by K V 7.2 channels or an about 25% reduction of those carried by heteromeric K V 7.2/K V 7.3 channels seems thus not to be sufficient to generate PNH. In contrast, functional analysis of the R207W mutation causing BFNC with PNH and of the R207Q mutation causing PNH alone establishes a different mechanism: after short depolarizations, both R207 mutants exert a strong dominant negative effect on co-expressed WT K V 7.2 channels brought on by a drastic depolarizing shift of the activation curve and a prominent slowing of the activation time course. Such a suppression of K V 7.2-mediated currents may well explain a hyperexcitability of peripheral motor neurons.
PNH is generated in the distal motor neurons, since lidocaine block of the proximal nerves does not suppress this activity, as was also shown in patients carrying the R207W mutation. 3, 15 This is suggested as well by the typical variable morphology of the electromyographic discharges observed in our patient ( figure 1B) . Thus, spontaneous depolarizations of presumably short duration at nodes of Ranvier and maybe near the nerve terminals, where K V 7.2 channels are probably localized, 25, 30, 31 may lead to spontaneous action potentials when activation of K V 7.2 channels is largely suppressed by dominant mutations. Interestingly, K V 7.2 and K V 7.3 may show a different subcellular distribution in peripheral motor neurons: K V 7.2 immunoreactivity was found in nodes of Ranvier, whereas the one for K V 7.3 was found clearly outside of nodes in rat sciatic nerves. 25 Thus, the 1:1:2 co-expression experiment, which did not reveal a difference compared to WT for the R207Q mutant in contrast to R207W, might not be relevant for the hyperexcitability of peripheral motor neurons. However, this result could serve as one explanation for the nonpenetrance of neonatal seizures in the patient carry-ing the R207Q mutation, since a close colocalization was detected for K V 7.2 and K V 7.3 in axon initial segments of pyramidal neurons of the hippocampus and cortex. 25 Another reason for the lack of neonatal seizures of the patient presented here might be simply a different genetic background compensating the hyperexcitability of the CNS in the neonatal period.
Our findings also correlate with the molecular level, on which it is conceivable that the bulky tryptophan residue causes a more severe disruption of the alpha-helical structure of the S4 segment than the more conservative change to a glutamine which at least has a similar size as arginine and preserves the alpha-helix. Since voltage-gated K ϩ channels form tetramers, 32,33 the observed dominant effect of 
3 (n ϭ 6), and R207W/K V 7.2/K V 7.3 (n ϭ 5) channels were obtained as described in the legend to figure 2D and plotted as means Ϯ SEM. figure 2E and are shown as means Ϯ SEM, n ϭ 5-7.
the mutant subunits could be explained by the cooperativity of the four voltage sensors during channel opening. [34] [35] [36] PNH is commonly treated symptomatically with anticonvulsant drugs. Retigabine is an anticonvulsant specifically enhancing K V 7 channel activity, which is currently under investigation in phase III clinical trials for the treatment of focal epilepsy. Retigabine induces the opposite of the two myokymia-causing mutations, that is a hyperpolarizing shift of the activation curve of K V 7 channels resulting in a stabilization of the membrane potential. [37] [38] [39] Our results clearly showed that the pronounced depolarizing shift of the activation curve caused by the R207Q mutation could be reversed by retigabine resulting in an increased current amplitude at physiologically relevant subthreshold voltages. This is in agreement with the molecular mechanism of retigabine, since the negative shift of the activation curve was shown to be caused most probably by binding to the activation gate of K V 7 channels and not the voltage sensor. 27, 40 The drug should not only have a positive influence on KCNQ2-related PNH, but also be of benefit in other forms of the disease, since the enhancement of K V 7 channels should generally reduce the firing of peripheral motor neurons. We therefore propose to consider retigabine as a new therapeutic option in PNH.
The electromyographic and clinical pattern of PNH observed in our patient was similar to those described in patients carrying the R207W mutation. 15 All patients presented with permanent myokymia, in particular finger twitching as shown in the supplementary video, and with typical myokymic discharges on EMG ( figure 1B ). An early onset and a lack of progression, which are not typical for autoimmune-mediated PNH, may reflect hallmarks of a KCNQ2-related disorder, while the motor signs themselves represent a common phenotype observed also in other forms of PNH with distinct molecular etiologies. 2 Our results show that KCNQ2 mutations can cause idiopathic PNH alone, so that this gene should be considered for molecular diagnosis, also in sporadic cases without a family history. Finally, retigabine might become a new treatment option in PNH, not only for KCNQ2-related cases.
Figure 4
Effect of the K V 7 opener retigabine on the R207Q mutation (A) Conductance-voltage curves of homomeric K V 7.2 and R207Q channels were constructed before and after application of 100 M retigabine (RGB) as described in the legend to figure 2B . Retigabine led to a hyperpolarizing shift of the voltage of half-maximal activation, V 0.5 , for both WT and mutant channels. Parameters were as follows: K V 7.2: V 0.5 ϭ Ϫ50.3 Ϯ 2.1 mV; V 0.5 (ϩRGB) ϭ Ϫ74.9 Ϯ 2.7 mV; R207Q: V 0.5 ϭ Ϫ26.1 Ϯ 1.9 mV; V 0.5 (ϩRGB) ϭ Ϫ53.3 Ϯ 1.9 mV (p Ͻ 1 E-5 for both conditions). The inset depicts a current trace of R207Q elicited at Ϫ40 mV before and after application of 100 M retigabine, clearly demonstrating an increment of the current by retigabine. (B) Dose-response curves for the activation of K V 7.2 WT and R207Q channels by retigabine. The relative hyperpolarizing shift of the voltage of half-maximal activation, V 0.5 , was plotted against the logarithm of different concentrations of RGB. Lines represent a fit of the Hill function to the data points as described in Methods. The Hill coefficient, nH, was 0.6 (K V 7.2) and 0.8 (R207Q), respectively. Data are shown as means Ϯ SEM, n ϭ 6-8.
